Evaluation of homœopathic therapy in 129 asymptomatic HIV carriers

Abstract

To assess the role of homœopathic medicines in the treatment of the asymptomatic phase of HIV infection, a pilot research study was undertaken by the Central Council for Research in Homœopathy (India) starting in May 1989. 129 symptomatic HIV carriers (120 male and 9 female) were treated with homœopathic medicines on the basis of the individuals' constitutional (both mental/emotional and physical) characteristics. The medicines were prescribed in potencies varying from 30 CH to 10M and in varying dosage, depending on the age and constitution of the individual patients. 12 of the patients studied have reverted back to negative serology for HIV antibodies after treatment varying from 3 to 16 months (mean duration of treatment between entry and reversal of seroconversion for HIV antibodies 7.25 months). All patients who continue to remain symptom free are receiving follow-up treatment. Efforts are being made to evaluate their haematological and immunological status in detail.

Key Words

Homœopathy - HIV infection - Anti-HIV antibodies

¹ Director, Central Council for Research in Homœopathy, B-1/6, Community Centre, Janakpuri, New Delhi 110 058.

² Research Officer, Central Council for Research in Homœopathy, B-1/6, Community Centre, Janakpuri, New Delhi 110 058.

³ Research Officer, Regional Research Institute of Homœopathy, Irla Naka, Vile Parle, Bombay.

⁴ Assistant Research Officer, Regional Research Institute of Homœopathy, Irla Naka, Vile Parle, Bombay.